Bristol-Myers Squibb (NYSE: BMY), colloquially referred to as BMS, is a pharmaceutical corporation, formed by a 1989 merger between pharmaceutical companies Bristol-Myers Company and Squibb Corporation. Its Chairman and CEO is Peter R. Dolan, and it is headquartered in New York City. Its primary R&D sites are located in New Jersey and Connecticut, with other sites around the US, in Ireland and in other countries.

BMS is on the Forbes 500 list and is one of the Top 10 companies for working mothers according to Working Mother Media.

BMS is known partially for the fact that Lance Armstrong has appeared in several of the company's marketing campaigns. This is due to the fact that the company helped to combat Armstrong's testicular cancer.

Products

Bristol-Myers Squibb manufactures prescription pharmaceuticals, Over-the-Counter drugs and health care products in several therapeutic areas. It is also the parent company of Mead Johnson which manufactures nutritional products such as Enfamil baby formulas and infant vitamin supplements like Tri-Vi-Sol.

Taxol

At one time, BMS held the solitary contract to harvest the bark of endangered yew trees on United States territory for the manufacture of chemotherapy drug paclitaxel (Taxol®). Current paclitaxel production comes from renewable sources. BMS also held the original paclitaxel license, but there are now multiple generic producers.